Auxly Cannabis (Germany) Performance
| 3KF Stock | EUR 0.01 0.01 47.00% |
Auxly Cannabis holds a performance score of 8 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -6.66, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Auxly Cannabis are expected to decrease by larger amounts. On the other hand, during market turmoil, Auxly Cannabis is expected to outperform it. Use Auxly Cannabis sortino ratio, maximum drawdown, and the relationship between the total risk alpha and treynor ratio , to analyze future returns on Auxly Cannabis.
Risk-Adjusted Performance
8 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Auxly Cannabis Group are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Auxly Cannabis reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Quick Ratio | 8.17 | |
| Fifty Two Week Low | 0.4430 | |
| Fifty Two Week High | 1.1000 |
Auxly |
Auxly Cannabis Relative Risk vs. Return Landscape
If you would invest 2.38 in Auxly Cannabis Group on September 12, 2024 and sell it today you would lose (1.32) from holding Auxly Cannabis Group or give up 55.46% of portfolio value over 90 days. Auxly Cannabis Group is currently producing 4.0177% returns and takes up 35.5876% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than Auxly, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Auxly Cannabis Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Auxly Cannabis' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Auxly Cannabis Group, and traders can use it to determine the average amount a Auxly Cannabis' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1129
| Best Portfolio | Best Equity | 3KF | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 35.59 actual daily | 96 96% of assets are less volatile |
Expected Return
| 4.02 actual daily | 80 80% of assets have lower returns |
Risk-Adjusted Return
| 0.11 actual daily | 8 92% of assets perform better |
Based on monthly moving average Auxly Cannabis is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Auxly Cannabis by adding it to a well-diversified portfolio.
Auxly Cannabis Fundamentals Growth
Auxly Stock prices reflect investors' perceptions of the future prospects and financial health of Auxly Cannabis, and Auxly Cannabis fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Auxly Stock performance.
| Return On Equity | -35.01 | |||
| Return On Asset | -9.93 | |||
| Current Valuation | 321.75 M | |||
| Shares Outstanding | 565 M | |||
| Price To Earning | 20.65 X | |||
| Price To Book | 1.15 X | |||
| Price To Sales | 328.84 X | |||
| Revenue | 1.51 M | |||
| EBITDA | (12.93 M) | |||
| Cash And Equivalents | 156.23 M | |||
| Cash Per Share | 0.37 X | |||
| Total Debt | 68.94 M | |||
| Debt To Equity | 29.30 % | |||
| Book Value Per Share | 0.49 X | |||
| Cash Flow From Operations | (13.7 M) | |||
| Earnings Per Share | (0.07) X | |||
About Auxly Cannabis Performance
By analyzing Auxly Cannabis' fundamental ratios, stakeholders can gain valuable insights into Auxly Cannabis' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Auxly Cannabis has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Auxly Cannabis has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Auxly Cannabis Group Inc. operates as an integrated cannabis company. Auxly Cannabis Group Inc. was incorporated in 1987 and is based in Vancouver, Canada. Cannabis Wheaton operates under Drug Manufacturers - Specialty Generic classification in Germany and is traded on Frankfurt Stock Exchange.Things to note about Auxly Cannabis Group performance evaluation
Checking the ongoing alerts about Auxly Cannabis for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Auxly Cannabis Group help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Auxly Cannabis Group is way too risky over 90 days horizon | |
| Auxly Cannabis Group has some characteristics of a very speculative penny stock | |
| Auxly Cannabis Group appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 1.51 M. Net Loss for the year was (20.6 M) with profit before overhead, payroll, taxes, and interest of 6.47 M. | |
| Auxly Cannabis Group has accumulated about 156.23 M in cash with (13.7 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.37, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing Auxly Cannabis' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Auxly Cannabis' stock is overvalued or undervalued compared to its peers.
- Examining Auxly Cannabis' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Auxly Cannabis' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Auxly Cannabis' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Auxly Cannabis' stock. These opinions can provide insight into Auxly Cannabis' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Auxly Stock analysis
When running Auxly Cannabis' price analysis, check to measure Auxly Cannabis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Auxly Cannabis is operating at the current time. Most of Auxly Cannabis' value examination focuses on studying past and present price action to predict the probability of Auxly Cannabis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Auxly Cannabis' price. Additionally, you may evaluate how the addition of Auxly Cannabis to your portfolios can decrease your overall portfolio volatility.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |